Olanzapine
Private Olanzapine testing in London for £218, measuring one therapeutic drug level with specialist results expected in around 5 days.
Turnaround time
5 business days
Biomarkers count
1
Book your test
Choose Service Type
Professional phlebotomist comes to you
+ £{{ home_visit_fee }}
Visit our clinic for your test
{{ clinic_visit_fee > 0 ? '+ £' + clinic_visit_fee : 'Free' }}
Home Visit Details
Home visits require at least 24 hours notice.
Select a clinic: Sorting by distance…
{{ clinicAddress(clinic) }}
{{ clinicAddress(selectedClinic) }}
Select a date
Select an hour
Available time slots: {{ timeSlots.length}}
Overview of the Olanzapine Test
The Olanzapine blood test measures the concentration of Olanzapine in the bloodstream, providing specialist therapeutic drug-monitoring information for people taking this antipsychotic medication.
The test assesses 1 specialist drug-monitoring biomarker: Olanzapine.
Olanzapine is an atypical antipsychotic medicine used in the management of conditions including schizophrenia and bipolar disorder.
Clinical response varies considerably between individuals.
The same prescribed dose can produce different blood concentrations because medication absorption and metabolism differ.
Therapeutic drug monitoring can therefore be useful where treatment response, adherence, drug interactions or possible toxicity is uncertain.
Olanzapine is metabolised principally through hepatic pathways that include CYP1A2.
Smoking is particularly important.
Chemicals in tobacco smoke can induce CYP1A2 and increase Olanzapine clearance.
People who smoke can therefore have lower concentrations on the same dose than non-smokers.
If somebody substantially reduces or stops smoking, Olanzapine concentrations can increase even though the prescribed dose has not changed.
This can increase the risk of adverse effects.
Other medicines can also alter Olanzapine concentrations.
Fluvoxamine can increase exposure, while some enzyme-inducing medicines can lower it.
Blood-level testing is not required routinely for every person taking Olanzapine.
It is most useful where there is a clear clinical question.
The result should always be interpreted with the dose, sample timing, smoking status, symptoms and treatment response.
What Does the Olanzapine Test Check?
The test measures circulating Olanzapine concentration for therapeutic drug monitoring. This test measures 1 specialist biomarker.
Olanzapine
Measures blood Olanzapine concentration, supporting assessment of medication exposure, adherence, interactions and possible excessive or insufficient drug levels.
Who May Benefit From the Olanzapine Test?
Olanzapine monitoring can be useful where there is uncertainty about drug exposure or clinical response.
People with an unexpectedly poor response despite prescribed treatment - A low concentration can raise questions about exposure, adherence or metabolism.
People experiencing possible dose-related adverse effects - A higher concentration can contribute to sedation or other adverse effects.
People who have recently stopped or substantially reduced smoking - Olanzapine levels can rise after smoking cessation.
People who have recently started smoking regularly - Increased CYP1A2 activity can reduce Olanzapine concentrations.
People starting or stopping an interacting medicine - Drug interactions can alter Olanzapine exposure.
People with uncertainty about medication adherence - Drug-level testing can provide objective information about recent exposure.
People with significant liver impairment under specialist management - Metabolism may be altered.
People specifically referred for antipsychotic therapeutic drug monitoring - The result can support individualised prescribing decisions.
How to Prepare
Do not skip or alter an Olanzapine dose unless your prescribing clinician has specifically instructed you to do so.
Smoking cessation can increase Olanzapine exposure and should be communicated to the treating team.
Symptoms and Reasons to Consider the Olanzapine Test
Blood-level testing is generally driven by treatment circumstances rather than symptoms alone.
Unexpected excessive sedation - Higher medication exposure can contribute to drowsiness.
Dizziness or impaired alertness after a dose change - Drug concentration may have changed.
Poor symptom control despite an apparently adequate dose - Measuring exposure can help clarify one possible explanation.
A major change in smoking behaviour - Smoking status can substantially influence Olanzapine metabolism.
New adverse effects after an interacting medication is started - Drug interactions can increase exposure.
Uncertainty about whether medication is being absorbed or taken consistently - Therapeutic monitoring can provide supporting information.
Marked confusion, reduced consciousness, severe neurological symptoms or suspected Olanzapine overdose requires urgent medical assessment.
Do not stop or change prescribed Olanzapine without advice from the clinician responsible for treatment.
How to Book Your Olanzapine Test
The Olanzapine blood test can be booked privately for specialist therapeutic drug monitoring.
Choose the Olanzapine
Select the individual Olanzapine drug-level blood test online.
Select your sample collection option
Choose an in-clinic blood draw or professional home or hotel phlebotomy able to meet the required sample timing.
Attend your appointment
A trained healthcare professional collects the required blood sample and dose timing should be documented.
Laboratory analysis
Your specimen undergoes specialist measurement of Olanzapine.
Receive your results securely
Your authorised result is delivered securely and should be reviewed alongside dose, smoking status, symptoms and clinical response.
When Will I Receive My Results?
The current specialist laboratory turnaround for Olanzapine is approximately 5 days after laboratory receipt.
This is a referral therapeutic drug-monitoring assay rather than a routine chemistry test.
The sample undergoes quantitative drug analysis, quality control and specialist authorisation.
Understanding Your Results
The Olanzapine concentration should be interpreted according to the dose and exact time of collection.
A lower-than-expected result can reflect rapid metabolism, smoking, an interacting medicine, inconsistent medication use or collection at a different point in the dosing interval.
A higher-than-expected result can occur after a dose increase, smoking cessation, metabolic inhibition or altered clearance.
A concentration alone does not determine whether treatment is effective.
Some people respond well at relatively low concentrations, while others may require a different clinical approach despite apparently adequate exposure.
The numerical result should therefore be interpreted by the prescribing clinician.
Smoking status is particularly important because tobacco smoke can substantially alter Olanzapine metabolism.
Why Book With London Blood Tests?
London Blood Tests provides private Olanzapine therapeutic drug monitoring for people receiving antipsychotic treatment.
Measures Olanzapine concentration directly - The test provides objective information about medication exposure.
Useful when treatment response is uncertain - Low exposure can be identified as one possible explanation.
Can support adverse-effect assessment - Higher drug concentrations may contribute to dose-related effects.
Particularly relevant when smoking habits change - Tobacco smoke strongly influences CYP1A2 activity.
Useful when interacting medicines are prescribed - Some drugs substantially alter Olanzapine metabolism.
Can provide adherence information - A measured concentration can support assessment of recent medication exposure.
Specialist laboratory analysis - Samples undergo dedicated therapeutic drug monitoring.
Clear pricing - The Olanzapine test costs £218.
Private Olanzapine Blood Test in London
London Blood Tests provides private Olanzapine blood-level testing for people requiring therapeutic drug monitoring.
The test costs £218 and measures 1 specialist medication biomarker.
Results are expected approximately 5 days after laboratory receipt.
The result should be interpreted by the prescribing clinician alongside dose timing, smoking status and treatment response.